Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Interdisciplinary Care: The Health Care Team-II01:18

Interdisciplinary Care: The Health Care Team-II

2.2K
An interdisciplinary team includes many healthcare professionals working together and utilizing their skills, knowledge, and expertise to provide holistic and quality patient care. Here are a few more healthcare professionals.
Physical Therapist
A physical therapist (PT) aims to restore function or prevent additional impairment in a patient following an injury or disease. Massage, heat, cold, water, sonar waves, exercises, and electrical stimulation are some treatments used by PTs to treat...
2.2K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

2.0K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.0K
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

170
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
170
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

2.9K
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
2.9K
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

206
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
206

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of Viral Hepatitis in Three Public Health Clinics in the Kingston Metropolitan Area, Jamaica, 2022.

The American journal of tropical medicine and hygiene·2026
Same author

Tetanus.

Lancet (London, England)·2026
Same author

No time to wait: resilience as a cornerstone for primary health care across Latin America and the Caribbean, a World Bank-PAHO Lancet Regional Health Americas Commission.

Lancet regional health. Americas·2025
Same author

[The role of the Pan American Committee for Safe Vaccination (COPAVASE) in strengthening safe vaccination in the AmericasO papel do Comitê Pan-Americano de Vacinação Segura (COPAVASE) no fortalecimento da vacinação segura nas Américas].

Revista panamericana de salud publica = Pan American journal of public health·2025
Same author

Lessons for sustaining the elimination of measles, rubella, and congenital rubella syndrome in the Caribbean.

Revista panamericana de salud publica = Pan American journal of public health·2024
Same author

Adaptation of WHO COVID-19 guidelines by Caribbean countries and territories.

Bulletin of the World Health Organization·2024

Related Experiment Video

Updated: Jan 19, 2026

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

9.2K

The Caribbean Immunization Technical Advisory Group (CITAG); A unique NITAG.

Tracy Evans-Gilbert1, Karen N Lewis-Bell2, J Peter Figueroa3

  • 1Department of Pediatrics, Cornwall Regional Hospital, Montego Bay, Jamaica.

Vaccine
|September 21, 2019
PubMed
Summary

The Caribbean established a regional technical advisory group for immunization to address limited expertise in small island nations. This initiative aims to improve evidence-based decision-making and combat declining vaccination rates.

Keywords:
Capacity buildingDecision-makingEvidence-based policyHealth policyNational Immunization Technical Advisory Group (NITAG)Routine immunization

More Related Videos

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

22.0K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.3K

Related Experiment Videos

Last Updated: Jan 19, 2026

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

9.2K
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

22.0K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.3K

Area of Science:

  • Public Health
  • Vaccinology
  • Health Policy

Background:

  • The Global Vaccine Action Plan mandated National Immunization Technical Advisory Groups (NITAGs) by 2020.
  • Caribbean nations faced challenges establishing individual NITAGs due to limited technical expertise and geographical fragmentation.
  • The Caribbean Immunization Technical Advisory Group (CITAG) was formed in 2018 to provide a unified approach.

Discussion:

  • Declining immunization rates and global outbreaks of vaccine-preventable diseases pose a significant risk to the Caribbean, a major tourist destination.
  • CITAG provides a common framework for policy and evidence-based decision-making tailored to the region's unique context.
  • Challenges include resource limitations, diverse healthcare systems, and the need for sustained political commitment.

Key Insights:

  • A regional collaborative body like CITAG is crucial for overcoming resource constraints in small island developing states.
  • Strengthening immunization programs through expert technical advice is essential for disease prevention and control.
  • Evidence-based policy development is key to maintaining high vaccination coverage and achieving elimination goals.

Outlook:

  • CITAG's continued efforts are vital for bolstering immunization programs and protecting the Caribbean population from vaccine-preventable diseases.
  • The model of a regional technical advisory group could be adapted for other geographically dispersed regions.
  • Sustained investment and collaboration are necessary to ensure the long-term success of CITAG and regional immunization goals.